Metraipolis › archive › dc_720e4b4cbc5b

In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A — Europe PMC PMID:42188633

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42188633
DOI
10.3390/toxins18050231
License (as archived)
solo-consultazione
Archived
2026-11-01T16:18:14.126Z
SHA-256 of the archived text
5af014deb9289e66a18dfa9a63a7f96fa77608455690fc3a6a3f06ac4b6c825b
Stable URL of this page
https://metraipolis.com/documento/dc_720e4b4cbc5b

How to cite

In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A — Europe PMC PMID:42188633 — Europe PMC (en), https://europepmc.org/article/MED/42188633 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_720e4b4cbc5b (Metraipolis archive dc_720e4b4cbc5b, sha256 5af014deb9289e66a18dfa9a63a7f96fa77608455690fc3a6a3f06ac4b6c825b)
BibTeX
@misc{dc720e4b4cbc5b,
  title = {In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A — Europe PMC PMID:42188633},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42188633},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_720e4b4cbc5b; sha256 5af014deb9289e66a18dfa9a63a7f96fa77608455690fc3a6a3f06ac4b6c825b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42188633. Agents can read the archived copy with the MCP tool read_document.